受强制性开放获取政策约束的文章 - Akhil Khera了解详情
可在其他位置公开访问的文章：4 篇
Pathophysiology and management of monoclonal gammopathy of renal significance
A Jain, R Haynes, J Kothari, A Khera, M Soares, K Ramasamy
Blood advances 3 (15), 2409-2423, 2019
强制性开放获取政策： UK Medical Research Council
Myeloma Genome Project Panel is a comprehensive targeted genomics panel for molecular profiling of patients with multiple myeloma
P Sudha, A Ahsan, C Ashby, T Kausar, A Khera, MH Kazeroun, CC Hsu, ...
Clinical Cancer Research 28 (13), 2854-2864, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, UK Medical Research …
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort …
F Djebbari, A Rampotas, F Panitsas, WY Lim, C Lees, I Tsagkaraki, ...
Plos one 17 (1), e0262388, 2022
强制性开放获取政策： National Institute for Health Research, UK
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients
A Rampotas, F Djebbari, F Panitsas, C Lees, I Tsagkaraki, AR Gomes, ...
European Journal of Haematology 106 (4), 563-573, 2021
强制性开放获取政策： National Institute for Health Research, UK
出版信息和资助信息由计算机程序自动确定